Ginsenoside Rg1 ameliorates glomerular fibrosis during kidney aging by inhibiting NOX4 and NLRP3 inflammasome activation in SAMP8 mice
- 1 May 2020
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 82, 106339
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81970630, 81671384)
This publication has 50 references indexed in Scilit:
- Anatomic and Physiologic Changes of the Aging KidneyClinics in Geriatric Medicine, 2013
- Oxidative Stress and Nucleic Acid Oxidation in Patients with Chronic Kidney DiseaseOxidative Medicine and Cellular Longevity, 2013
- Oligomeric Aβ-Induced Microglial Activation is Possibly Mediated by NADPH OxidaseNeurochemical Research, 2012
- Ginsenoside-Rg1 protects podocytes from complement mediated injuryJournal of Ethnopharmacology, 2011
- Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidasesKidney International, 2011
- Ginsenoside Rg1 modulation on thrombospondin‐1 and vascular endothelial growth factor expression in early renal fibrogenesis in unilateral obstructionPhytotherapy Research, 2010
- Ginsenoside Rg1, a major active component isolated from Panax notoginseng, restrains tubular epithelial to myofibroblast transition in vitroJournal of Ethnopharmacology, 2009
- Thiazolidinediones: A novel class of drugs for the prevention of diabetic nephropathy?Kidney International, 2007
- Localizing NADPH Oxidase–Derived ROSScience's STKE, 2006
- Characteristics of the Inhibition of NADPH Oxidase Activation in Neutrophils by Apocynin, a Methoxy-Substituted CatecholAmerican Journal of Respiratory Cell and Molecular Biology, 1994